Indegene Ltd

Indegene Ltd, a small-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a modest day gain of 0.66% to close at ₹511.20, the stock’s technical indicators present a complex picture, reflecting mixed signals that investors should carefully analyse amid broader market dynamics.

Indegene Ltd, a small-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Recent technical indicators reveal a complex picture with mixed signals from MACD, RSI, Bollinger Bands, and moving averages, reflecting cautious investor sentiment amid price declines.

Indegene Ltd, a small-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a 2.11% gain on 10 June 2026, the company’s overall technical indicators present a mixed picture, with bullish signals on weekly MACD and Bollinger Bands contrasting with mildly bearish daily moving averages and monthly Bollinger Bands. This nuanced technical landscape, combined with a recent downgrade in its Mojo Grade from Hold to Sell, warrants a detailed analysis for investors navigating the evolving market dynamics.

Indegene Ltd, a small-cap player in the healthcare services sector, has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish signals on weekly charts, the overall technical landscape presents a complex picture, prompting a downgrade in its Mojo Grade from Hold to Sell as of 8 June 2026.

Indegene Ltd, a small-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Sell to Hold as of 3 June 2026. This change reflects a nuanced shift in the company’s technical outlook, balanced against flat financial performance and valuation considerations. The upgrade comes amid a complex backdrop of mixed signals across quality, valuation, financial trends, and technical indicators.

Indegene Ltd, a small-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend. Recent technical indicators such as MACD, RSI, and moving averages reveal a complex picture of cautious optimism amid mixed signals, prompting a reassessment of the stock’s near-term outlook.

Indegene Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 May 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 28 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Indegene Ltd is rated Sell by MarketsMOJO, with this rating last updated on 11 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 17 May 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Indegene Ltd, a small-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a 2.45% gain on 12 May 2026, the company’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages, prompting a downgrade in its Mojo Grade from Hold to Sell.

Indegene Ltd, a healthcare services company, has seen its investment rating upgraded from Sell to Hold as of 5 May 2026, reflecting a nuanced shift in its overall outlook. This change is driven by a complex interplay of factors across quality, valuation, financial trends, and technical indicators, signalling cautious optimism amid mixed performance metrics.

Indegene Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. The stock’s recent price surge of 6.94% to ₹534.20, coupled with mixed technical readings, suggests cautious optimism amid ongoing volatility in the healthcare services sector.

The Sensex advanced 0.52% on 4 May 2026, yet Indegene Ltd outpaced the broader market with a 7.28% gain, touching an intraday high of Rs 533.8. This 7.59-percentage-point outperformance over its Healthcare Services sector peers signals a distinctly stock-specific rally rather than a market-wide lift.

Indegene Ltd, a healthcare services small-cap, posted a mixed set of results for the quarter ended March 2026, with record net sales and PBDIT overshadowed by a notable decline in net profit and earnings per share. The company’s financial trend has shifted from positive to flat, prompting a downgrade in its Mojo Grade from Hold to Sell as investors weigh the implications of margin pressures and subdued bottom-line growth.

Indegene Limited, a healthcare services provider with a market capitalisation of ₹12,031.53 crores, reported a concerning performance for Q4 FY26, with net profit declining 32.23% year-on-year to ₹79.70 crores despite achieving record quarterly revenue of ₹1,003.40 crores. The stock, trading at ₹499.45, has struggled over the past year, declining 9.12% whilst the broader market fell 4.84%, reflecting investor concerns about deteriorating profitability metrics.

Indegene Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with the latest insights into the company’s performance and outlook.